Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges

被引：0
|
作者：
Volpe, Massimo [1 ]
Patrono, Carlo [2 ]
机构：
[1] Sapienza Univ Rome, St Andrea Hosp, Dept Cardiol, Rome, Italy
[2] Catholic Univ, Sch Med, Dept Pharmacol, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 03期
关键词：
SACUBITRIL/VALSARTAN;
D O I：
10.1093/eurheartj/ehac649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [31] Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
    Andrea Passantino
    Caterina Rizzo
    Domenico Scrutinio
    Alberto Palazzuoli
    Heart Failure Reviews, 2023, 28 : 683 - 695
  • [32] Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
    Passantino, Andrea
    Rizzo, Caterina
    Scrutinio, Domenico
    Palazzuoli, Alberto
    HEART FAILURE REVIEWS, 2023, 28 (03) : 683 - 695
  • [33] Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?
    Qing Zhang
    Yu Kang
    Siqi Tang
    Cheuk-Man Yu
    Current Cardiology Reports, 2021, 23
  • [34] Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis
    Younes, Ahmed M.
    Salem, Mahmoud
    Maraey, Ahmed
    Nomigolzar, Soroush
    Sewell, Kerry
    Khalil, Mahmoud
    Elzanaty, Ahmed
    Saeyeldin, Ayman
    Dar, Moahad
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 51 - 56
  • [35] Intersection Between Diabetes and Heart Failure: Is SGLT2i the "One Stone for Two Birds" Approach?
    Zhang, Qing
    Kang, Yu
    Tang, Siqi
    Yu, Cheuk-Man
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (11)
  • [36] Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
    Pradhan, Akshyaya
    Vohra, Shweta
    Vishwakarma, Pravesh
    Sethi, Rishi
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (06) : 1855 - 1862
  • [37] The Bigger the Ship, the Harder It Is to Turn: Continued Clinical Inertia With SGLT2i Utilization in Heart Failure
    Lyle, Melissa
    Santos-Gallego, Carlos G.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (09) : 1098 - 1099
  • [38] Indirect treatment comparison of ARNI vs SGLT2i in heart failure with reduced ejection fraction: a reconciliation of previous network meta-analyses
    Felizzi, F. Federico
    Bhowmik, D.
    Kumar, V.
    Schwende, H.
    Pascual Figal, D. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 201 - 201
  • [39] SGLT2 Inhibition in Heart Failure with Preserved Ejection Fraction - The New Frontier
    Aguiar-Neves, Ines
    Santos-Ferreira, Diogo
    Fontes-Carvalho, Ricardo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (01)
  • [40] UP TO 12 MONTH TRENDS IN CLINICAL AND BIOCHEMICAL PARAMETERS AFTER SGLT2I THERAPY IN PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
    Pugliese, R.
    Alcidi, G.
    Ioannoni, S.
    Diomede, D.
    Romano, M.
    Correale, M.
    Benvenuto, M.
    Gronda, E.
    Brunetti, N.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
12345